An announcement from Pulse Biosciences (PLSE) is now available.
Burke T. Barrett has been appointed the new President and CEO of Pulse Biosciences, Inc., bringing with him a wealth of experience from his previous CEO role at CardioFocus, Inc. and significant contributions in medical device innovation. As he takes the helm on May 12, 2024, Barrett is set to also serve as the principal executive and financial officer. His predecessor, Kevin P. Danahy, shifts focus to lead the commercialization of the CellFX nsPFA Percutaneous Electrode System. Barrett’s comprehensive background includes over thirty U.S. patents and a history of senior roles in various medical technology firms, underpinning his readiness to steer Pulse Biosciences towards future milestones.
For detailed information about PLSE stock, go to TipRanks’ Stock Analysis page.
